Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 752

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 5
Chunk 752
---
,
our internal control over financial reporting.

ITEM
9B. OTHER INFORMATION.

None.

ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

Not
applicable.

161

PART
III

ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information
about directors, executive officers and corporate governance is presented under the same captions in our definitive Proxy Statement for
the Annual Meeting of Shareowners held in the first quarter of fiscal 2025 and is incorporated herein by reference.

Insider Trading Policy

We maintain, and periodically review,
an insider trading policy that governs the purchase, sale and/or disposition of our securities by our directors, officers, employees
and contractors who may have access to and/or possession of material non-public information. We have implemented processes that we believe
are reasonably designed to promote compliance by us and by the covered persons with insider trading laws, rules and regulations and applicable
listing standards. A copy of our Insider Trading Policy is filed as Exhibit 19.1 to this Annual Report.

ITEM
11. EXECUTIVE COMPENSATION

Information
about executive compensation is presented under the same captions in our definitive Proxy Statement for the Annual Meeting of
Shareowners held in the first quarter of fiscal 2025 and is incorporated herein by reference.

ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information
about security ownership of certain beneficial owners and management and related stockholder matters is presented under the same
captions in our definitive Proxy Statement for the Annual Meeting of Shareowners held in the first quarter of fiscal 2025 and is
incorporated herein by reference.

ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

Pre-Business
Combination Related Party Transactions of Aesther

Certain
Relationships and Related Transactions

The
following is a summary of transactions since our formation on June 17, 2021, to which we have been a participant in which the amount
involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets as of December 31, 2024, and in which
any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of the
foregoing persons, had or will